
A Rare but Serious Fungal Infection in Type 1 Diabetes: What Parents and Patients Should Know
A case report documents how a 14-year-old with newly diagnosed Type 1 diabetes developed a life-threatening fungal infection during treatment for diabetic ketoacidosis. Understanding the warning signs may help with early detection.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Rhino-orbital-cerebral mucormycosis (ROCM) is a rare but aggressive fungal infection that can develop in people with Type 1 diabetes, especially during diabetic ketoacidosis (DKA)
- Early symptoms include fever, nasal congestion, eye and facial swelling, headache, and nerve-related symptoms—signs that warrant immediate medical attention
- Diagnosis requires specialized testing like plasma mNGS (molecular testing) and nasal biopsy to confirm the fungus
- Treatment involves antifungal medication (liposomal amphotericin B) combined with surgical removal of infected tissue, and requires careful monitoring for complications
- Multidisciplinary medical team collaboration, including clinical pharmacists, is important for optimizing treatment and managing side effects
What Is Rhino-Orbital-Cerebral Mucormycosis?
Rhino-orbital-cerebral mucormycosis (ROCM) is a serious infection caused by Mucorales fungi. It grows rapidly, affects the sinuses, eye area, and brain, and carries a high risk of disability and death if not treated quickly. The infection often begins subtly, with symptoms that can be mistaken for other conditions, leading to delayed diagnosis.
How This Case Unfolded
A 14-year-old girl came to the hospital with chest pain and was diagnosed with Type 1 diabetes complicated by diabetic ketoacidosis (DKA)—a serious condition requiring intensive treatment. Within days of DKA treatment, she developed a high fever, nasal congestion, progressive swelling of her eyelids and around her eyes, headache, and dysfunction in her cranial nerves. These new symptoms led doctors to test for infection.
Two diagnostic tests—plasma mNGS (a molecular test) and a biopsy of nasal tissue—both identified the fungus Rhizopus delemar as the cause. This confirmed the diagnosis of ROCM.
Treatment and Complications
The medical team began treatment with liposomal amphotericin B, an antifungal medication given at a dose of 5 mg per kilogram of body weight daily, combined with nasal endoscopic surgery to remove infected tissue. Initially, the infection was controlled. However, serious complications emerged: anemia (low red blood cell count) worsened, and the patient developed severe low potassium levels. These side effects required close monitoring and management.
After a four-week course of antifungal treatment and multidisciplinary care led by clinical pharmacists, the patient's condition stabilized. The case underscores how important it is for different medical specialists to work together to optimize medication regimens and monitor for harmful side effects.
Why This Matters for the Type 1 Diabetes Community
While ROCM is rare, people with Type 1 diabetes—particularly during DKA—are at higher risk. Currently, there are no established clinical guidelines for diagnosing and treating mucormycosis in children, making each case a clinical challenge. This case report documents a complete diagnostic and treatment process, which may help medical teams recognize and respond to similar presentations more quickly.
If you or your child experience fever, nasal congestion, facial or eye swelling, headache, or vision changes during or after DKA treatment, seek urgent medical attention. Early detection and rapid treatment are critical.
Evidence label
Source: Frontiers in medicine. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Diagnosis & Early DetectionA Simple Blood Test May Help Doctors Assess How Severe Your DKA IsPubMed indexed literature
- Diagnosis & Early DetectionA New Approach to Finding Type 1 Diabetes Early: Testing During Routine CheckupsPubMed indexed literature
- Diagnosis & Early DetectionSingle Autoantibody: What It Means When Your Child Tests Positive for One Type 1 MarkerPubMed indexed literature
- Diagnosis & Early DetectionKetosis-Prone Type 2 Diabetes: New Clues to an Immune Mix-UpPubMed indexed literature
- Diagnosis & Early DetectionWhy Screening for Type 1 Diabetes Before Symptoms MatterPubMed indexed literature
- Diagnosis & Early DetectionTesting for Type 1 Before Symptoms Appear: What a Real-World Pilot LearnedPubMed indexed literature